Laboratory of Experimental Rheumatology and Neuroendocrine Immunology, Department of Internal Medicine I, University Hospital Regensburg, Germany.
Department of Orthopedic Surgery, University Hospital Regensburg, Germany.
Brain Behav Immun. 2015 May;46:180-91. doi: 10.1016/j.bbi.2015.02.022. Epub 2015 Feb 28.
Density of sympathetic nerve fibers decreases in inflamed arthritic tissue tested by immunoreactivity towards tyrosine-hydroxylase (TH, catecholaminergic key enzyme). Since sympathetic nerve fibers may change phenotype from catecholaminergic to cholinergic (example: sweat glands), loss of nerve fibers may relate to undetectable TH. We aimed to investigate possible catecholaminergic-to-cholinergic transition of sympathetic nerve fibers in synovial tissue of animals with arthritis, and patients with rheumatoid arthritis (RA) and osteoarthritis (OA), and we wanted to find a possible transition factor.
Nerve fibers were detected by immunofluorescence towards TH (catecholaminergic) and vesicular acetylcholine transporter (cholinergic). Co-culture experiments with sympathetic ganglia and lymphocytes or osteoclast progenitors were designed to find stimulators of catecholaminergic-to-cholinergic transition (including gene expression profiling).
In mouse joints, an increased density of cholinergic relative to catecholaminergic nerve fibers appeared towards day 35 after immunization, but most nerve fibers were located in healthy joint-adjacent skin or muscle and almost none in inflamed synovial tissue. In humans, cholinergic fibers are more prevalent in OA synovial tissue than in RA. Co-culture of sympathetic ganglia with osteoclast progenitors obtained from healthy but not from arthritic animals induced catecholaminergic-to-cholinergic transition. Osteoclast mRNA microarray data indicated that leukemia inhibitory factor (LIF) is a candidate transition factor, which was confirmed in ganglia experiments, particularly, in the presence of progesterone.
In humans and mice, catecholaminergic-to-cholinergic sympathetic transition happens in less inflamed tissue but not in inflamed arthritic tissue. Under healthy conditions, presence of cholinergic sympathetic nerve fibers may support the cholinergic anti-inflammatory influence recently described.
通过免疫反应检测酪氨酸羟化酶(TH,儿茶酚胺能关键酶),炎症性关节炎组织中交感神经纤维密度降低。由于交感神经纤维的表型可能从儿茶酚胺能转变为胆碱能(例如:汗腺),因此神经纤维的丧失可能与无法检测到 TH 有关。我们旨在研究关节炎动物模型和类风湿关节炎(RA)及骨关节炎(OA)患者滑膜组织中交感神经纤维发生儿茶酚胺能向胆碱能转变的可能性,并寻找可能的转变因子。
通过针对 TH(儿茶酚胺能)和囊泡乙酰胆碱转运体(胆碱能)的免疫荧光检测神经纤维。设计了交感神经节与淋巴细胞或破骨细胞祖细胞的共培养实验,以寻找儿茶酚胺能向胆碱能转变的刺激物(包括基因表达谱分析)。
在免疫后第 35 天,在小鼠关节中,相对于儿茶酚胺能神经纤维,胆碱能神经纤维的密度增加,但大多数神经纤维位于健康关节相邻的皮肤或肌肉中,而在炎症性滑膜组织中几乎没有。在人类中,OA 滑膜组织中的胆碱能纤维比 RA 更常见。与来自健康而非关节炎动物的破骨细胞祖细胞共培养的交感神经节诱导了儿茶酚胺能向胆碱能转变。破骨细胞 mRNA 微阵列数据表明白血病抑制因子(LIF)是一个候选的转变因子,在神经节实验中得到了证实,特别是在孕激素存在的情况下。
在人类和小鼠中,儿茶酚胺能向胆碱能的交感神经转变发生在炎症较轻的组织中,而不是在炎症性关节炎组织中。在健康状态下,存在胆碱能交感神经纤维可能支持最近描述的胆碱能抗炎作用。